The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity

[1]  G. De Sarro,et al.  Current role of perampanel in pediatric epilepsy , 2017, Italian Journal of Pediatrics.

[2]  E. Yang,et al.  Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients , 2017, Korean journal of pediatrics.

[3]  P. Curatolo,et al.  Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy , 2017, Brain and Development.

[4]  L. Hirsch,et al.  Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy. , 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[5]  V. Sikirica,et al.  Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison , 2017, European Child & Adolescent Psychiatry.

[6]  R. Sankar,et al.  Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy , 2017, Experimental Neurology.

[7]  Qiang Liu,et al.  Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials , 2017, Journal of clinical and experimental neuropsychology.

[8]  P. Striano,et al.  Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter study , 2016, Epilepsy Research.

[9]  L. Lagae,et al.  Adjunctive perampanel in adolescents with inadequately controlled partial‐onset seizures: A randomized study evaluating behavior, efficacy, and safety , 2016, Epilepsia.

[10]  I. García-Morales,et al.  One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[11]  A. Aldenkamp,et al.  Psychiatric and Behavioural Disorders in Children with Epilepsy:an ILAE Task Force Report , 2016 .

[12]  A. Aldenkamp,et al.  Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Epilepsy and ADHD. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[13]  A. Aldenkamp,et al.  Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Anxiety, depression and childhood epilepsy. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[14]  W. Kronenberger,et al.  Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges , 2016, Neuropsychiatric disease and treatment.

[15]  K. Meador,et al.  Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial , 2016, Epilepsia.

[16]  J. Nobrega,et al.  N-Methyl-d-Aspartate Receptor Subunits and Alcohol , 2016 .

[17]  J. Isojarvi,et al.  Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome. , 2015, Pediatric neurology.

[18]  Hai-chen Yang,et al.  Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel , 2015, Epilepsia.

[19]  T. Matsuzaka,et al.  [Effectiveness and safety of long-term levetiracetam treatment in patients with refractory epilepsy]. , 2015, No to hattatsu = Brain and development.

[20]  L. Lagae,et al.  Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[21]  J. Jansen,et al.  Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy , 2015, Acta neurologica Scandinavica.

[22]  P. Camfield,et al.  Incidence, prevalence and aetiology of seizures and epilepsy in children. , 2015, Epileptic disorders : international epilepsy journal with videotape.

[23]  A. Palmini,et al.  Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies , 2015, Epilepsy & Behavior.

[24]  U. Stephani,et al.  Effectiveness and Tolerability of Perampanel in Children and Adolescents with Refractory Epilepsies: First Experiences , 2015, Neuropediatrics.

[25]  M. Kamate,et al.  Safety of lacosamide in children with refractory partial epilepsy , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[26]  L. Selemon.  Frontal lobe synaptic plasticity in development and disease: modulation by the dopamine D1 receptor. , 2014, Current pharmaceutical design.

[27]  S. Hong,et al.  Cognitive and Psychosocial Effects of Oxcarbazepine Monotherapy in Newly Diagnosed Partial Epilepsy , 2014, Clinical neuropharmacology.

[28]  D. Hirtz,et al.  Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy , 2013, Neurology.

[29]  A. Herigstad,et al.  Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD) , 2013, Seizure.

[30]  J. Matson,et al.  A comparison of tantrum behavior profiles in children with ASD, ADHD and comorbid ASD and ADHD. , 2013, Research in developmental disabilities.

[31]  K. Hornbuckle,et al.  A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications , 2013, Pharmacoepidemiology and drug safety.

[32]  C. Helmstaedter,et al.  The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting , 2013, Epilepsy & Behavior.

[33]  Munhyang Lee,et al.  Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy , 2012, Brain and Development.

[34]  Marco Mula,et al.  Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan , 2012, The Lancet.

[35]  Daniel B. Legoff,et al.  A Long-Term Open-Label Extension Study Assessing Cognition and Behavior, Tolerability, Safety, and Efficacy of Adjunctive Levetiracetam in Children Aged 4 to 16 Years With Partial-Onset Seizures , 2012, Journal of child neurology.

[36]  E. Casella,et al.  Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: A Brazilian sample study and literature review , 2011, Epilepsy & Behavior.

[37]  C. Reilly,et al.  Attention deficit hyperactivity disorder (ADHD) in childhood epilepsy. , 2011, Research in developmental disabilities.

[38]  M. Brodie.  Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy , 2011 .

[39]  S. Marino,et al.  Zonisamide discontinuation due to psychiatric and cognitive adverse events , 2010, Neurology.

[40]  E. Sellers,et al.  Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers , 2010, Epilepsy & Behavior.

[41]  B. Bourgeois,et al.  Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy , 2010, Epilepsy & Behavior.

[42]  U. Brandl,et al.  Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate. , 2010, Neuropediatrics.

[43]  Romina Moavero,et al.  Attention deficit hyperactivity disorder in children with epilepsy , 2010, Brain and Development.

[44]  Subin Park,et al.  Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system. , 2009, Epileptic disorders : international epilepsy journal with videotape.

[45]  Hai-chen Yang,et al.  Neurocognitive effects of adjunctive levetiracetam in children with partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, noninferiority trial , 2009, Epilepsia.

[46]  O. Hvalby,et al.  N-methyl-d-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder , 2009, Neuroscience.

[47]  K. Gilby.  A new rat model for vulnerability to epilepsy and autism spectrum disorders , 2008, Epilepsia.

[48]  V. Russell,et al.  Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar–Kyoto rat) , 2008, Brain Research.

[49]  F. Donati,et al.  The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures , 2007, Seizure.

[50]  Ho-Won Lee,et al.  Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients , 2007, Journal of clinical neurology.

[51]  L. Carmant,et al.  Nonlesional Frontal Lobe Epilepsy (FLE) of Childhood: Clinical Presentation, Response to Treatment and Comorbidity , 2006, Epilepsia.

[52]  A. Aldenkamp,et al.  The Effect of the New Antiepileptic Drug Rufinamide on Cognitive Functions , 2006, Epilepsia.

[53]  Jaroslaw Harezlak,et al.  ADHD and epilepsy in childhood. , 2003, Developmental medicine and child neurology.

[54]  A. Serdaroğlu,et al.  Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities , 2003, Journal of Child Neurology.

[55]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[56]  D. Riva,et al.  Carbamazepine Withdrawal in Children With Previous Symptomatic Partial Epilepsy: Effects on Neuropsychologic Function , 1999, Journal of child neurology.

[57]  R. Shalev,et al.  Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? , 1997, The Journal of pediatrics.

[58]  S. Helmers,et al.  Behavioral Side Effects of Gabapentin in Children , 1996, Epilepsia.

[59]  K. Goulden,et al.  Aggression in Children Treated with Clobazam for Epilepsy , 1994, Clinical neuropharmacology.

[60]  E. Vining,et al.  Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. , 1987, Pediatrics.

[61]  B. Rourke,et al.  Central processing deficiencies in children: toward a developmental neuropsychological model. , 1982, Journal of clinical neuropsychology.